Th1/Th17-linked transcription factors TBX21 and RORC were associated with clinical response to rituximab in treatment-resistant schizophrenia.

Bylund S, Eklund D, Humble MB, Bejerot S, Wikström S.

Open source

DOI
10.1016/j.bbih.2026.101270
Published
2026-05-27
Container
Brain Behav Immun Health
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bbih.2026.101270,
  title = {Th1/Th17-linked transcription factors TBX21 and RORC were associated with clinical response to rituximab in treatment-resistant schizophrenia.},
  author = {Bylund S and  Eklund D and  Humble MB and  Bejerot S and  Wikström S.},
  year = {2026},
  journal = {Brain Behav Immun Health},
  doi = {10.1016/j.bbih.2026.101270},
  url = {https://doi.org/10.1016/j.bbih.2026.101270}
}

RIS

TY  - JOUR
TI  - Th1/Th17-linked transcription factors TBX21 and RORC were associated with clinical response to rituximab in treatment-resistant schizophrenia.
AU  - Bylund S
AU  -  Eklund D
AU  -  Humble MB
AU  -  Bejerot S
AU  -  Wikström S.
PY  - 2026
JO  - Brain Behav Immun Health
DO  - 10.1016/j.bbih.2026.101270
UR  - https://doi.org/10.1016/j.bbih.2026.101270
ER  - 

APA

S, B., D, E., MB, H., S, B., & S., W. (2026). Th1/Th17-linked transcription factors TBX21 and RORC were associated with clinical response to rituximab in treatment-resistant schizophrenia.. Brain Behav Immun Health. https://doi.org/10.1016/j.bbih.2026.101270

Source records